Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2023-11-03 | 2023-12-14 | 209116 |
TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2023-11-03 | 2023-12-14 | 209119 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2024-02-29 | 2024-07-18 | 220992 |
TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2024-03-21 | 2024-06-29 | 222944 |
TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2024-04-18 | 2024-06-29 | 225480 |
TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2024-05-09 | 2024-06-29 | 227462 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2024-06-07 | 2024-10-17 | 229939 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2024-07-04 | 2024-11-14 | 232198 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-04-21 | 2022-06-17 | 159192 |
TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2022-06-09 | 2022-08-20 | 162277 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-12-01 | 2022-12-15 | 176800 |
TEVA-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Resolved | 2022-05-19 | 2025-04-29 | 160980 |
TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2022-04-21 | 2022-08-19 | 159213 |
TEVA-TRAMADOL/ACETAMINOPHEN | 325MG 37.5MG | TABLET | Resolved | 2021-02-25 | 2021-06-03 | 134738 |
TEVA-TRAMADOL/ACETAMINOPHEN | 325MG 37.5MG | TABLET | Resolved | 2021-03-18 | 2021-03-25 | 135955 |
TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2019-10-24 | 2020-09-03 | 97150 |
TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183407 |
TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108003 |
TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108006 |
TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108009 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253182 |
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253160 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |